Titlebook: Neuropharmacology of New Psychoactive Substances (NPS); The Science Behind t Michael H. Baumann,Richard A. Glennon,Jenny L. Wil Book 2017 S

Landlocked

Clinical Pharmacology of the Synthetic Cathinone Mephedrone,amics and pharmacokinetics. This chapter reviews the available published data on patterns of mephedrone use, its acute and chronic effects, and its pharmacokinetic properties. More human research is needed to elucidate the safety, toxicity, and addiction potential of mephedrone and related NPS.

認(rèn)識(shí)

Book 2017rming worldwide increase in the abuse of NPS in recent years. NPS are cheap, easy to obtain, and often legally available. In this volume, leading experts summarize the latest studies regarding the molecular mechanisms of action, behavioral effects, and adverse consequences of popular NPS. Specific c

CHIDE

少量

Book 2017hapters clarify the differences between various types of NPS, namely: stimulants, cannabinoids and hallucinogens. Thus, this volume broadens our understanding of NPS and provides insight into the rapidly evolving “new drug” phenomenon.?.??.

沉思的魚

1866-3370 opular NPS.Specific chapters clarify the differences between.Designer drugs, or new psychoactive substances (NPS), are synthetic chemicals that mimic the effects of classic drugs of abuse. There has been an alarming worldwide increase in the abuse of NPS in recent years. NPS are cheap, easy to obtai

撕裂皮肉

云狀

Neuropharmacology of New Psychoactive Substances (NPS)978-3-319-52444-3Series ISSN 1866-3370 Series E-ISSN 1866-3389

MULTI

Michael H. Baumann,Richard A. Glennon,Jenny L. WilLeading experts summarize the latest studies regarding the molecular mechanisms of action, behavioral effects, and adverse consequences of popular NPS.Specific chapters clarify the differences between

EXALT

Current Topics in Behavioral Neuroscienceshttp://image.papertrans.cn/n/image/664340.jpg

約會(huì)